Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2mutation carriers-Reference-Cited by-同舟云学术

Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2mutation carriers

Published:2010-11-29 Issue:6 Volume:12 Page:
ISSN:1465-542X
Container-title:Breast Cancer Research
language:en
Short-container-title:Breast Cancer Res

Author:

Walker Logan C, ,Fredericksen Zachary S,Wang Xianshu,Tarrell Robert,Pankratz Vernon S,Lindor Noralane M,Beesley Jonathan,Healey Sue,Chen Xiaoqing,Stoppa-Lyonnet Dominique,Tirapo Carole,Giraud Sophie,Mazoyer Sylvie,Muller Danièle,Fricker Jean-Pierre,Delnatte Capucine,Schmutzler Rita K,Wappenschmidt Barbara,Engel Christoph,Schönbuchner Ines,Deissler Helmut,Meindl Alfons,Hogervorst Frans B,Verheus Martijn,Hooning Maartje J,van den Ouweland Ans MW,Nelen Marcel R,Ausems Margreet GEM,Aalfs Cora M,van Asperen Christi J,Devilee Peter,Gerrits Monique M,Waisfisz Quinten,Szabo Csilla I,Easton Douglas F,Peock Susan,Cook Margaret,Oliver Clare T,Frost Debra,Harrington Patricia,Evans D Gareth,Lalloo Fiona,Eeles Ros,Izatt Louise,Chu Carol,Davidson Rosemarie,Eccles Diana,Ong Kai-Ren,Cook Jackie,Rebbeck Tim,Nathanson Katherine L,Domchek Susan M,Singer Christian F,Gschwantler-Kaulich Daphne,Dressler Anne-Catharina,Pfeiler Georg,Godwin Andrew K,Heikkinen Tuomas,Nevanlinna Heli,Agnarsson Bjarni A,Caligo Maria Adelaide,Olsson Håkan,Kristoffersson Ulf,Liljegren Annelie,Arver Brita,Karlsson Per,Melin Beatrice,Sinilnikova Olga M,McGuffog Lesley,Antoniou Antonis C,Chenevix-Trench Georgia,Spurdle Amanda B,Couch Fergus J, , , , ,

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/bcr2785.pdf

Reference30 articles.

1. Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrjakoski K, Kallioniemi OP, Thompson D, Evans C, Peto J, et al: Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet. 2003, 72: 1117-1130. 10.1086/375033.

2. Chen S, Iversen ES, Friebel T, Finkelstein D, Weber BL, Eisen A, Peterson LE, Schildkraut JM, Isaacs C, Peshkin BN, Corio C, Leondaridis L, Tomlinson G, Dutson D, Kerber R, Amos CI, Strong LC, Berry DA, Euhus DM, Parmigiani G: Characterization of BRCA1 and BRCA2 mutations in a large United States sample. J Clin Oncol. 2006, 24: 863-871. 10.1200/JCO.2005.03.6772.

3. Easton DF, Ford D, Bishop DT: Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am J Hum Genet. 1995, 56: 265-271.

4. Ford D, Easton DF, Peto J: Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet. 1995, 57: 1457-1462.

5. Milne RL, Osorio A, Cajal TR, Vega A, Llort G, de la Hoya M, Diez O, Alonso MC, Lazaro C, Blanco I, Sanchez-de-Abajo A, Caldes T, Blanco A, Grana B, Duran M, Velasco E, Chirivella I, Cardenosa EE, Tejada MI, Beristain E, Miramar MD, Calvo MT, Martinez E, Guillen C, Salazar R, San Roman C, Antoniou AC, Urioste M, Benitez J: The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain. Clin Cancer Res. 2008, 14: 2861-2869. 10.1158/1078-0432.CCR-07-4436.

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Computational analysis of sodium-dependent phosphate transporter SLC20A1/PiT1 gene identifies missense variations C573F, and T58A as high-risk deleterious SNPs;Journal of Biomolecular Structure and Dynamics;2023-06-07

2. A new inverse probability of selection weighted Cox model to deal with outcome-dependent sampling in survival analysis;2023-02-07

3. TGF-β signaling networks in the tumor microenvironment;Cancer Letters;2022-12

4. Antrodia salmonea suppresses invasion and metastasis in triple-negative breast cancer cells by reversing EMT through the NF-κB and Wnt/β-catenin signaling pathway;Food and Chemical Toxicology;2019-02

5. Breast Cancer Prevention;Fundamentals of Cancer Prevention;2019